Avita Medical
RCEL
80 hedge funds and large institutions have $40.7M invested in Avita Medical in 2025 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 23 increasing their positions, 23 reducing their positions, and 13 closing their positions.
211% more call options, than puts
Call options by funds: $342K | Put options by funds: $110K
46% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 13
8% more funds holding
Funds holding: 74 → 80 (+6)
2.35% more ownership
Funds ownership: 26.72% → 29.07% (+2.3%)
0% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 23
29% less capital invested
Capital invested by funds: $57.3M → $40.7M (-$16.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$2.6M |
| 2 |
Morgan Stanley
New York
|
+$976K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$671K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$473K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$427K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$554K |
| 2 |
Goldman Sachs
New York
|
-$534K |
| 3 |
DIM
Delta Investment Management
San Francisco,
California
|
-$427K |
| 4 |
EFA
Evernest Financial Advisors
Carmel,
Indiana
|
-$411K |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$367K |
RCEL Hedge Fund Activity: Q2 2025 in Review
80 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Avita Medical (RCEL) for Q2 2025, worth a combined $40.7M — down 29% from $57.3M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new RCEL positions and 13 closed out — a net gain of 6 holders — while 23 added to existing stakes and 23 trimmed.
The largest buyer was Millennium Management, adding an estimated $2.6M. The largest seller was AQR Capital Management, cutting an estimated $554K.
- 80 institutional investors held Avita Medical (RCEL) as of Q2 2025, up from 74 in Q1 2025.
- Funds reported $40.7M of Avita Medical stock for Q2 2025, down 29% quarter-over-quarter.
- 19 funds opened new Avita Medical positions in Q2 2025 and 13 closed out, a net change of +6 holders.
- The largest Avita Medical buyer in Q2 2025 was Millennium Management, an estimated $2.6M added.
- The largest Avita Medical seller in Q2 2025 was AQR Capital Management, an estimated $554K sold.
Based on aggregated 13F filings for Q2 2025.